Safaricom CEO Bob Collymore Appointed to National Cancer Institute Board
Safaricom Chief Executive Officer, Bob Collymore, has been appointed as a board member of the country’s National Cancer Institute. This appointment comes barely 2 years after the man at the helm of Kenya’s biggest company, took medical leave to return to the United Kingdom for 9 months of cancer treatment.
A gazette notice, referencing Kenya’s Ministry of Health Cabinet Secretary Sicily Kariuki, named Collymore among the appointment parastatal heads and members, alongside Royal Media Services Digital Content Manager, Mercy Oburu, herself a cancer survivor. Oburu is also a member of the Board of the Africa Cancer Foundation.
Recently, Collymore revealed plans to not renew his contract as Safaricom CEO come August, due to what he has termed “health reasons”. Reuters News Agency had on April 29th published a story claiming that internal rows over leadership wrangles and succession had erupted at the telecommunications giant, ricocheting through countless news outlets. This prompted Safaricom PLC Chairman Nicholas Nganga to release a statement to the public assuring stakeholders of the Board’s confidence in Bob’s leadership, also having put in place a ‘robust recruitment process that adheres to global best practices.
The appointees to Kenya’s National Cancer Institute will serve for the next three years. Also joining Collymore and Oburu is the Kenya Network of Cancer Organisations (Kenco) chairperson David Makumi, who has been at the forefront of highlighting the plight of Kenyans living with cancer for over 10 years.
According to the Union for International Cancer Control (UICC) website, the National Cancer Institute is a corporate body established under the Cancer Control Act and serves as the coordinating body for all cancer control activities in Kenya. The Institute main mandate is to advise the Cabinet Secretary of Health on the overall priorities that should be accorded to cancer prevention and control in Kenya.